Enlivex Ltd (ENLV)

• Market cap: $153M
• 1 day: 2.54%
• 5 days: -13.19%
• 1 month: -9.12%
• 3 months: -41.86%
• 6 months: -23.8%
• Year to date: -16.06%
• 1 year: -39.65%
• 5 years: -93.23%
• 10 years: -99.13%
• Sector: Healthcare
• Industry: Biotechnology

About: Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Employees: 34